Combined with the above analysis, we hypothesize that RRM2 may be involved in the regulation of apoptosis through its interactions with the Bcl-2 pathway and that RRM2 expression may be positively correlated with NSCLC development. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.